Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-053206)

Filing Details

Accession Number:: 0001209191-17-053206
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-09-18 17:46:46
Reporting Period:: 2017-09-15

Accepted Time:: 2017-09-18 17:46:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1604464	Atara Biotherapeutics Inc.	ATRA	Biological Products, (No Disgnostic Substances) (2836)	460920988

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612095	Christopher Haqq	611 Gateway Boulevard Suite 900 South San Francisco CA 94080	Evp, R&D & Chief Scientific Of	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-09-15	6,000	$15.30	349,305	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	17,312	Indirect	See footnote
Common Stock	2,688	Indirect	See footnote

Footnotes

Transaction pursuant to Rule 10b5-1 Plan adopted September 27, 2016.
The shares are held by the Chris Haqq 2014 GRAT, of which the Reporting Person is trustee.
The shares are held by The Havenside Trust, of which the Reporting Person is trustee.